We and our investors are committed to establishing and implementing fully transparent governance and compliance practices:

Our core principles are to:

  •  Effective Board of Directors
  • Recruit the best industry-specific management team
  • Define the Human Capital governance process

Dr. Abdulkader Tawfik

Dr. Abdulkader Tawfik

(Senior Consultant and Chairman of Scientific Committee)
  • Ph.D. in Medical Microbiology, Vanderbilt University, Nashville, TN, USA.
  • BSc in Pharmacy, College of Pharmacy, University of Riyadh, Riyadh, KSA.

Background

  • Dr. Tawfik has more than eight years of experience in the pharmaceutical industry, and more than twenty-five years of experience in the field of Immunology and Microbiology. He has published more than fifty research papers and books.
  • During his academic career he held several academic and research positions, Chairman of the Department of Clinical Laboratory Sciences, College of Applied Medical Sciences; and Director of Research Center, College of Pharmacy, King Saud University.

Professional and Industry Experience

  • DDC Consultant and Chairman of Scientific Committee.
  • Within the pharmaceutical industry, Dr. Tawfik has worked in several positions like Chief Operating Officer at Saudi Biotechnology Manufacturing Corporation (Saudi Bio), General Project Supervisor at Saudi pharmaceutical Industry &Medical Appliances (SPIMACO).
  • He also worked as a consultant at Biotechnology Research Center at King AbdulAziz City for Science and Technology (KACST).
Dr. Mathew Cherian

Dr. Mathew Cherian

(Consultant)
  • Ph.D. in Chemical Engineering, University of Rhode Island, Kingston, RI, USA.
  • Master's degree in Chemical Engineering, Indian Institute of Technology, Kharagpur, India.
  • BSc in Chemical Engineering, National Institute of Technology, Warangal, India.

Background

  • Dr. Mathew Cherianisa highly experienced pharmaceutical executive with a broad range of experience in the US and Europe. He has held leadership positions in R&D at Baxter, Astellas, Pharmacia, and Pfizer. He also has significant experience in doing due diligence for product and enterprise license in Uganda question, integration of newly acquired assets, portfolio management, and intellectual property.

Professional and Industry Experience

  • With deep knowledge, knowledge, and experience in peptides, proteins, and monoclonal antibodies, he has led teams involved in formulation development, analytical development, process development, and scaleup, technology transfer, and regulatory filings.
  • Heading large pharmaceutical development departments in the US and Europe, his extensive prior experience includes development to sterile liquids, freeze dried products, sterile powder fills, and oral solids
  • He also has significant experience in developing drugs packaged in devices, like syringes(glass and plastic), cartridges, and combinations of drugs and devices. With deep hands-on experience in developing drugs in IV bags and sterilized is perseddosage forms like emulsions, suspensions, liposomesandlipid complexes, many of the formulations he helped to develop have been used on several products including a liposomalantifungal that are currently in the market.
Eng. Tawfik F. Tawfik

Eng. Tawfik F. Tawfik

(Partner and General Manager)
  • Master of Management, University of Phoenix, USA
  • Bachelor of Science in Computer Engineering, University of Arizona, Tucson, USA

Background

Tawfik has more than 29 years of diverse experience in the IT, Construction, and Retail industries. He has proven entrepreneurial skills in managing the total business cycle and stakeholders.

Professional and Industry Experience

  • DDC Partner and General Manager

During the past years, he established and managed:

  • Drug Dimensions Company LLC.
  • Saudi Company for Equilibrium Development LLC. (SCED).
  • Technology Force LLC.
  • Worked for Microsoft international for more than four years.

DR. Tarek El Mansy

Background

Tarek has over 25 years of “local/regional” experience in the pharmaceutical and healthcare industries across the MENA region. He is a senior executive in supporting companies that wish to expand their business into the MENA region - dynamic and passionate, with a proven track record in management, international marketing, sales, operations, and driving sustainable growth across geographies and cultures.

Professional and Industry Experience      

DDC Chief Commercial Officer

  • Regional Head GCC countries - Abdi Ibrahim Pharmaceutical
  • General Manager GCC Countries - Pharma Science
  • Head of MENA Countries Cluster - Ivax Pharmaceuticals group
  • Director General - Yahmaa Medical Company
  • Business Development Director, MENA region and Canada
  • Drug & Poison information specialist - King Khalid University Hospital Saudi Ariab

Education

  • King Saud University in cooperation with Riyadh chamber of commerce Marketing Diploma integrated sales and marketing, Marketing / Marketing Management, General 1997 - 1998
  • King Saud University, College of Pharmacy BSc., Pharmacy, Pharmaceutical Sciences, and Administration 1981 - 1986